$HTLD
HEARTLAND EXPRESS INC

2023 Q2 Form 10-Q Financial Statement

#000079923323000021 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $306.2M $330.9M
YoY Change 63.03% 118.7%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $233.3M $248.5M
YoY Change 82.34% 138.83%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $48.34M $48.47M
YoY Change 98.84% 107.92%
% of Gross Profit
Operating Expenses $298.0M $314.8M
YoY Change 81.16% 136.46%
Operating Profit $16.23M $22.89M
YoY Change -84.55% 2.21%
Interest Expense -$5.519M $6.075M
YoY Change -3271.84% 4060.96%
% of Operating Profit -34.0% 26.54%
Other Income/Expense, Net
YoY Change
Pretax Income $10.71M $17.30M
YoY Change -89.81% -23.26%
Income Tax $2.940M $4.687M
% Of Pretax Income 27.45% 27.09%
Net Earnings $7.771M $12.61M
YoY Change -89.9% -24.82%
Net Earnings / Revenue 2.54% 3.81%
Basic Earnings Per Share $0.10 $0.16
Diluted Earnings Per Share $0.10 $0.16
COMMON SHARES
Basic Shares Outstanding 78.99M shares 78.99M shares
Diluted Shares Outstanding 79.08M shares 79.02M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.25M $55.51M
YoY Change -73.09% -70.33%
Cash & Equivalents $46.25M $55.51M
Short-Term Investments
Other Short-Term Assets $30.12M $19.77M
YoY Change 50.92% 102.27%
Inventory
Prepaid Expenses
Receivables $114.5M $126.2M
Other Receivables $7.927M $0.00
Total Short-Term Assets $198.8M $212.3M
YoY Change -32.88% -20.92%
LONG-TERM ASSETS
Property, Plant & Equipment $941.6M $938.4M
YoY Change 84.34% 98.82%
Goodwill $320.7M $320.7M
YoY Change 53.58% 90.54%
Intangibles $101.1M $102.4M
YoY Change 105.36% 370.68%
Long-Term Investments
YoY Change
Other Assets $34.52M $19.64M
YoY Change 77.44% 18.37%
Total Long-Term Assets $1.398B $1.400B
YoY Change 71.08% 106.33%
TOTAL ASSETS
Total Short-Term Assets $198.8M $212.3M
Total Long-Term Assets $1.398B $1.400B
Total Assets $1.597B $1.613B
YoY Change 43.43% 70.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $61.05M $47.49M
YoY Change 111.94% 134.2%
Accrued Expenses $74.30M $76.16M
YoY Change -0.09% 41.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.60M $13.31M
YoY Change 446.74%
Total Short-Term Liabilities $147.9M $146.6M
YoY Change 17.09% 89.01%
LONG-TERM LIABILITIES
Long-Term Debt $336.2M $352.6M
YoY Change 3798.61%
Other Long-Term Liabilities $45.19M $47.56M
YoY Change -19.11% 22.53%
Total Long-Term Liabilities $381.4M $599.3M
YoY Change 125.73% 371.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.9M $146.6M
Total Long-Term Liabilities $381.4M $599.3M
Total Liabilities $723.7M $745.9M
YoY Change 145.08% 264.59%
SHAREHOLDERS EQUITY
Retained Earnings $1.069B $1.063B
YoY Change 5.32% 13.1%
Common Stock $4.805M $5.104M
YoY Change -5.75% -0.16%
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.7M $201.2M
YoY Change -0.67% -0.49%
Treasury Stock Shares
Shareholders Equity $872.9M $866.6M
YoY Change
Total Liabilities & Shareholders Equity $1.597B $1.613B
YoY Change 43.43% 70.26%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $7.771M $12.61M
YoY Change -89.9% -24.82%
Depreciation, Depletion And Amortization $48.34M $48.47M
YoY Change 98.84% 107.92%
Cash From Operating Activities $30.81M $66.44M
YoY Change 47.33% 76.74%
INVESTING ACTIVITIES
Capital Expenditures $65.87M $42.15M
YoY Change -330.84% 91.33%
Acquisitions
YoY Change
Other Investing Activities $44.91M -$489.0K
YoY Change -862.98%
Cash From Investing Activities -$20.96M -$12.80M
YoY Change -39.11% 52.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.14M -$47.37M
YoY Change 604.56% 115426.83%
NET CHANGE
Cash From Operating Activities 30.81M $66.44M
Cash From Investing Activities -20.96M -$12.80M
Cash From Financing Activities -19.14M -$47.37M
Net Change In Cash -9.288M $6.275M
YoY Change -42.74% -78.49%
FREE CASH FLOW
Cash From Operating Activities $30.81M $66.44M
Capital Expenditures $65.87M $42.15M
Free Cash Flow -$35.05M $24.29M
YoY Change -170.89% 56.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000799233
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78988359 shares
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3200000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3300000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78989000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78984000 shares
CY2023Q1 htld Treasury Stock Shares1
TreasuryStockShares1
11700000 shares
CY2022Q4 htld Treasury Stock Shares1
TreasuryStockShares1
11705000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2022Q1 htld Restricted Cash And Investments Current Total
RestrictedCashAndInvestmentsCurrentTotal
900000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14900000 usd
CY2023Q1 htld Restricted Stock Shares Remaining Available
RestrictedStockSharesRemainingAvailable
579866 shares
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-100000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271 rate
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256 rate
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Entity File Number
EntityFileNumber
0-15087
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-0926999
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
901 Heartland Way,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
North Liberty,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
52317
CY2023Q1 dei City Area Code
CityAreaCode
319
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
645-7060
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
HTLD
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78988359 shares
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55506000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49462000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126170000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139819000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
10862000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
11293000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
19774000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
26069000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3139000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
212312000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
229782000 usd
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
94539000 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
94155000 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
144022000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
143899000 usd
CY2023Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6947000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6946000 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21598000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21652000 usd
CY2023Q1 htld Revenue Equipment
RevenueEquipment
990523000 usd
CY2022Q4 htld Revenue Equipment
RevenueEquipment
1000472000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
22286000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
15070000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1279915000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1282194000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
341509000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
308936000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
938406000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
973258000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
320675000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
320675000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
102410000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
103701000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19642000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19894000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1488000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1224000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17577000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20954000 usd
CY2023Q1 us-gaap Assets
Assets
1612510000 usd
CY2022Q4 us-gaap Assets
Assets
1669488000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
47492000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
62712000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31549000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30972000 usd
CY2023Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
17635000 usd
CY2022Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
18490000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
13307000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
13946000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10885000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12001000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12001000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
16088000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
18636000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9608000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
146564000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
156757000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6569000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6466000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
352645000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
399062000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6692000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8953000 usd
CY2023Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
199121000 usd
CY2022Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
207516000 usd
CY2023Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
34300000 usd
CY2022Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
35257000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
599327000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
657254000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
907000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
907000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4197000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4165000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1062672000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1051641000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
201157000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
201236000 usd
CY2023Q1 htld Stockholders Equity1
StockholdersEquity1
866619000 usd
CY2022Q4 htld Stockholders Equity1
StockholdersEquity1
855477000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1612510000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1669488000 usd
CY2023Q1 us-gaap Revenues
Revenues
330916000 usd
CY2022Q1 us-gaap Revenues
Revenues
151275000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
123333000 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
58638000 usd
CY2023Q1 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
33144000 usd
CY2022Q1 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
748000 usd
CY2023Q1 us-gaap Fuel Costs
FuelCosts
57528000 usd
CY2022Q1 us-gaap Fuel Costs
FuelCosts
29711000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15026000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5079000 usd
CY2023Q1 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
5543000 usd
CY2022Q1 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3209000 usd
CY2023Q1 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
11002000 usd
CY2022Q1 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
5566000 usd
CY2023Q1 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
2876000 usd
CY2022Q1 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
1078000 usd
CY2023Q1 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
48469000 usd
CY2022Q1 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
23311000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
17891000 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5798000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
6786000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4258000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
308026000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
128880000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22890000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22395000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
484000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
146000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
6075000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17299000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22541000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4687000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5766000 usd
CY2023Q1 htld Net Income
NetIncome
12612000 usd
CY2022Q1 htld Net Income
NetIncome
16775000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12612000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16775000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78987000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78929000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79022000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78953000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
855477000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12612000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1581000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-111000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
866619000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
727102000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
16775000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1579000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-230000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
742528000 usd
CY2023Q1 htld Net Income2
NetIncome2
12612000 usd
CY2022Q1 htld Net Income2
NetIncome2
16775000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48469000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23311000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
8659000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1744000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
152000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
271000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
269000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
6786000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4258000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-13649000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
8771000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4864000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1083000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10978000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3557000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
12850000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7369000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66442000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37593000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28859000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13648000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42149000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22029000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-489000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12801000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8381000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
41000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
41000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
47325000 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47366000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6275000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
29171000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64478000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173767000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70753000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202938000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
6121000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
232000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
142000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2059000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2058000 usd
CY2023Q1 htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
232000 usd
CY2022Q1 htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
1213000 usd
CY2023Q1 htld Common Stock Dividends Declared In Accounts Payable
CommonStockDividendsDeclaredInAccountsPayable
1581000 usd
CY2022Q1 htld Common Stock Dividends Declared In Accounts Payable
CommonStockDividendsDeclaredInAccountsPayable
1579000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55506000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187085000 usd
CY2023Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
746000 usd
CY2022Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
916000 usd
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
14501000 usd
CY2022Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
14937000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70753000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202938000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segments
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15200000 usd
CY2023Q1 htld Restricted Cash And Investments Current Total
RestrictedCashAndInvestmentsCurrentTotal
700000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2500000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2600000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Revenues
Revenues
330900000 usd
CY2022Q1 us-gaap Revenues
Revenues
151300000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24600000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3200000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14500000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15100000 usd
CY2022Q4 htld Restricted Cash And Investments Current Total
RestrictedCashAndInvestmentsCurrentTotal
800000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14300000 usd
CY2023Q1 htld Amortization Period Of Tires
AmortizationPeriodOfTires
two years
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 htld Increase Decrease Of Restricted Cash And Investments
IncreaseDecreaseOfRestrictedCashAndInvestments
200000 usd
CY2022 htld Increase Decrease Of Restricted Cash And Investments
IncreaseDecreaseOfRestrictedCashAndInvestments
1600000 usd
CY2023Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
102400000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
31600000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
94575000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23789000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70786000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 htld Net Income Loss Eps
NetIncomeLossEPS
12612000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78987000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
35000 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
12612000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79022000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q1 htld Net Income Loss Eps
NetIncomeLossEPS
16775000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78929000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000 shares
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16775000 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78953000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
6600000 shares
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 usd
CY2011Q3 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
900000 shares
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2021Q2 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
600000 shares
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
200000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
300000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y7M6D
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
40100 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.01
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
7000.0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.95
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
33100 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.02
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
14000.0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.70
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
25000.0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.17
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
12000.0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.51
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
27000.0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.37
CY2022Q3 htld Unsecured Credit Facility
UnsecuredCreditFacility
550000000 usd
CY2022Q3 htld Revolving Facility
RevolvingFacility
100000000 usd
CY2022Q3 htld Term Facility
TermFacility
450000000 usd
CY2022Q3 htld Revolving Facility
RevolvingFacility
100000000 usd
CY2022Q3 htld Available Issuance Of Line Of Credit
AvailableIssuanceOfLineOfCredit
50000000 usd
CY2022Q3 htld Swingline Facility
SwinglineFacility
20000000 usd
CY2022Q3 htld Uncommitted Accordion Feature
UncommittedAccordionFeature
275000000 usd
CY2023Q1 htld Max Annual Dividend
MaxAnnualDividend
10000000 usd
CY2023Q1 htld Debt Instrument Covenant Distributions Max Leverage Ratio
DebtInstrumentCovenantDistributionsMaxLeverageRatio
2.5
CY2023Q1 htld Debt Instrument Covenant Maximum Net Leverage Ratio
DebtInstrumentCovenantMaximumNetLeverageRatio
2.75
CY2023Q1 htld Debt Instrument Covenant Minimum Interest Coverage Ratio
DebtInstrumentCovenantMinimumInterestCoverageRatio
3
CY2023Q1 htld Term Sofr One Month Spread
TermSOFROneMonthSpread
0.011 rate
CY2023Q1 htld Applicable Margin Base
ApplicableMarginBase
0.0100 rate
CY2022Q3 htld Revolving Facility Related Party
RevolvingFacilityRelatedParty
8200000 usd
CY2022Q3 htld Term Facility Related Party
TermFacilityRelatedParty
36800000 usd
CY2023Q1 htld Outstanding Debt On Term Facility
OutstandingDebtOnTermFacility
330000000 usd
CY2023Q1 htld Outstanding Debt On Revolving Facility
OutstandingDebtOnRevolvingFacility
0 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
13600000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
86400000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 htld Weighted Average Interest Rate Credit Facility
WeightedAverageInterestRateCreditFacility
0.064 rate
CY2022Q2 htld Business Combination Long Term Debt
BusinessCombinationLongTermDebt
-46800000 usd
CY2023Q1 htld Business Combination Long Term Debt
BusinessCombinationLongTermDebt
-38000000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 htld Debt
Debt
9200000 usd
CY2023Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.044 rate
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 htld Finance Lease Obligations
FinanceLeaseObligations
28800000 usd
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.039 rate
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q1 htld Right Of Use Asset Associated With The Leased Terminal Facility
RightOfUseAssetAssociatedWithTheLeasedTerminalFacility
2700000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 htld Right Of Use Operating Lease Assets
RightOfUseOperatingLeaseAssets
14800000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038 rate
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8934000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
10862000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6193000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
8231000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3008000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
7511000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
151000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3901000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18286000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
30505000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
709000 usd
CY2023Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
1741000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
17577000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
28764000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10885000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11324000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6692000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17440000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5800000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5700000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4600000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4500000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-100000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5744000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
92000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
30000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5806000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
84400000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31

Files In Submission

Name View Source Status
0000799233-23-000021-index-headers.html Edgar Link pending
0000799233-23-000021-index.html Edgar Link pending
0000799233-23-000021.txt Edgar Link pending
0000799233-23-000021-xbrl.zip Edgar Link pending
exhibit3112023q1.htm Edgar Link pending
exhibit3122023q1.htm Edgar Link pending
exhibit3212023q1.htm Edgar Link pending
exhibit3222023q1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
htld-20230331.htm Edgar Link pending
htld-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
htld-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
htld-20230331_lab.xml Edgar Link unprocessable
htld-20230331_pre.xml Edgar Link unprocessable
htld-20230331_def.xml Edgar Link unprocessable
htld-20230331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending